Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_assertion evidence source_evidence_literature NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_assertion SIO_000772 16507781 NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_assertion wasDerivedFrom befree-20140225 NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_assertion wasGeneratedBy ECO_0000203 NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP871727.RAOZh9GKP8Ucdry8FmDKc7Dm3hZ65E9b9hjvTJJiOW5WI130_provenance.